Fibroheal Woundcare has received follow-on funding from KITVEN-the venture fund arm of Karnataka Government.
The company will be utilising these funds to enhance the delivery capabilities, scale up its manufacturing ability to cater to increased demands from the market. Recently, Fibroheal have enhanced their basket in terms of product offering by foraying into area of port closure dressings useful post minimally access surgeries and minimal invasive surgeries.
Vivek Mishra, CEO, Fibroheal Woundcare said, “Being pioneers in using silk proteins for wholistic woundcare including tough to heal wounds, injuries and scars, receiving following on funding support from existing investors like Bharat Tandon, KITVEN and Telama Investment highlights the trust they have in our company and its mission to be the most comprehensive wound care company addressing different types and stages of wounds. As we expand and prepare to grow leap and bounds, this investment will be very helpful in scale up process to address and grasp the huge opportunity lying ahead of us to make a huge impact in the way wounds are treated.”
A R Jayakumar, CEO, KITVEN Fund said, “KITVEN has always been in the forefront to support innovative product development companies across all sectors. In this endeavour, Fibroheal woundcare has been one the most promising company which has developed innovative wound care products using bio-degradable silk protein. We supported the company in their initial phase and we are elated to be part of the company’s expansion phase after seeing the market acceptability of their products.”
